- Olly Bridge joins as Chief Growth Officer, bringing over 20 years of diverse health & wellness experience to Wellteq
- Mr. Bridge led the growth of the world’s largest corporate health and wellness program at Global Corporate Challenge into 185 countries prior to its acquisition by Virgin Pulse
- Mr. Bridge was also the former designer and head of the corporate health business for Medibank, Australia’s largest health insurer
WellteQ Digital Health Inc. (CSE: WTEQ), (the “Company” or Wellteq”), is pleased to announce the appointment of Mr. Olly Bridge as Chief Growth Officer. Mr. Bridge will lead the growth strategy for Wellteq into North America, Latin America and the EMEA region.
Mr. Bridge comes to Wellteq from Medibank, Australia’s largest health insurer, where he led the design and deployment of both their corporate and retail policy holder digital health and wellness programs. The Medibank digital health program has been deployed to 3.5 million policy holders. Prior to Medibank, Mr. Bridge led the global sales development for Global Corporate Challenge, which when acquired by Virgin Pulse in 2015, was operating in 185 countries around the world. Virgin Pulse are currently the world’s largest corporate wellness provider.
Scott Montgomery, Wellteq CEO stated, “Olly built the global sales team for the world’s largest corporate health and wellness program and then he led Australia’s largest insurer’s successful transformation into a digital wellness provider for millions of its corporate and retail policy holders. At Wellteq, we have committed to onboarding exceptional talent and Olly is a world class sales growth leader for the broadening of our world class health and wellness solutions.”
Mr. Bridge stated, “I am honoured to lead Wellteq’s next stage of growth. My career has been driven by my deep-seated desire to impact health at a population scale. With my passion and experience in this space, coupled with the amazing platform offerings that Wellteq has developed, I can’t think of a better union.”
About WellteQ Digital Health Inc.
WellteQ Digital Health Inc. is a leading provider of corporate wellness solutions developed to provide data-driven personalized health and wellness coaching to engage its users in healthier behaviours. As an enterprise (business-to-business) model Wellteq currently has two main sectors of customers, employers and insurance companies. Wellteq have secured a large multinational portfolio of customers, including UBS, DBS and Bupa Insurance, and reseller partners like Willis Towers Watson, Advanced Human Imaging and Garmin. Wellteq is developing its newly acquired Internet of Medical Things (IoMT) technologies for connected patient applications in healthcare which will extend the Wellteq’s continuum of care from preventative wellness through to virtual healthcare.
|Bristol Investor Relations|
|T: (905) 326-1888 ext 1|
Cautionary Note Regarding Forward-Looking Statements:
This news release contains information or statements that constitute “forward-looking statements.” Such forward looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements, or developments to differ materially from the anticipated results, performance or achievements expressed or implied by such forward-looking statements. Forward-looking statements are statements that are not historical facts and are generally, but not always, identified by words such as “expects,” “plans,” “anticipates,” “believes,” “intends,” “estimates,” “projects,” “potential” and similar expressions, or that events or conditions “will,” “would,” “may,” “could” or “should” occur.
Forward looking information may include, without limitation, statements regarding the operations, business, financial condition, expected financial results, performance, prospects, opportunities, priorities, targets, goals, ongoing objectives, milestones, strategies and outlook of Wellteq, and includes statements about, among other things, future developments and the future operations, strengths and strategies of Wellteq. Forward-looking information is provided for the purpose of presenting information about management’s current expectations and plans relating to the future and readers are cautioned that such statements may not be appropriate for other purposes. These statements should not be read as guarantees of future performance or results.
The forward-looking statements made in this news release are based on management’s assumptions and analysis and other factors that may be drawn upon by management to form conclusions and make forecasts or projections, including management’s experience and assessments of historical trends, current conditions and expected future developments. Although management believes that these assumptions, analyses and assessments are reasonable at the time the statements contained in this news release are made, actual results may differ materially from those projected in any forward-looking statements. Examples of risks and factors that could cause actual results to materially differ from forward-looking statements may include: the timing and unpredictability of regulatory actions; regulatory, legislative, legal or other developments with respect to its operations or business; limited marketing and sales capabilities; early stage of the industry and product development; limited products; reliance on third parties; unfavourable publicity or consumer perception; general economic conditions and financial markets; the impact of increasing competition; the loss of key management personnel; capital requirements and liquidity; access to capital; the timing and amount of capital expenditures; the impact of COVID-19; shifts in the demand for Wellteq’s products and the size of the market; patent law reform; patent litigation and intellectual property; conflicts of interest; and general market and economic conditions.
The forward-looking information contained in this news release represents the expectations of Wellteq as of the date of this news release and, accordingly, is subject to change after such date. Readers should not place undue importance on forward-looking information and should not rely upon this information as of any other date. Wellteq undertakes no obligation to update these forward-looking statements in the event that management’s beliefs, estimates or opinions, or other factors, should change.
The CSE has neither approved nor disapproved the contents of this news release.